FDA Adverse Event Injury Summary report: N

BIOCARDIA UNIVERSAL DEFLECTABLE GUIDE CATHETER

MDR report key: 2144477 · Received June 22, 2011

Report

Report Number
3003610571-2011-00001
Event Type
Injury
Date Received
June 22, 2011
Date of Event
May 26, 2011
Report Date
June 16, 2011
Manufacturer
BIOCARDIA, INC.
Product Code
DQO
PMA / PMN Number
K012749
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
FL, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

PHYSICIAN/USER COMMENT: VENTRICULAR TACHYCARDIA IS FREQUENTLY PROVOKED DURING RETROGRADE LEFT VENTRICULAR CATHETER MANIPULATION. USUALLY IT IS A SELF-TERMINATING ARRHYTHMIA, BUT MAY ALSO BE SUSTAINED, PARTICULARLY IN PATIENTS WITH LEFT VENTRICULAR DISEASE. CARDIAC CATHETERIZATION LABORATORY PRACTICES PERMIT THE PROMPT RECOGNITION AND TREATMENT OF ARRHYTHMIAS. INFORMED CONSENT FORMS FOR CATHETERIZATION ADVISE PATIENTS OF THE RISK OF ARRHYTHMIAS. CONCLUSIONS: THERE IS NOTHING THAT CAN BE SEEN ON THIS CATHETER THAT WOULD INDICATE THAT IT DOES NOT CONFORM TO OUR SPECIFICATIONS. THERE ARE NO IRREGULARITIES OR OTHER FEATURES THAT WOULD SEEM LIKELY TO CAUSE ANY INJURY OR DAMAGE TO PATIENT ANATOMY.

Description of Event or Problem · 1

A SERIOUS ADVERSE EVENT OCCURRED POSSIBLY RELATED TO THE MORPH UNIVERSAL DEFLECTABLE GUIDE CATHETER, MODEL 00895. THE PATIENT HAD ISCHEMIC CARDIOMYOPATHY, VENTRICULAR REMODELING SURGERY, AND A FUNCTIONING AUTOMATIC INTERNAL DEFIBRILLATOR (WHICH WAS TURNED OFF FOR THE PROCEDURE) AND ENROLLED IN AN INVESTIGATIONAL CLINICAL TRIAL FOR STEM CELL THERAPY. LEFT HEART CATHETERIZATION WITH THE MORPH GUIDING CATHETER WAS ACCOMPLISHED OVER A GUIDEWIRE WITHOUT INCIDENT. THE INVESTIGATION HELICAL INFUSION CATHETER WAS RETRACTED INSIDE THE MORPH GUIDE, WHICH WAS NAVIGATED TO THE MID-ANTERIOR SEPTUM. WHEN THE TIP OF THE MORPH GUIDE TOUCHED THE ENDOCARDIUM OF THIS SEGMENT, THE PATIENT IMMEDIATELY CONVERTED TO RAPID PULSELESS MONOMORPHIC VENTRICULAR TACHYCARDIA. THE ARRHYTHMIA WAS SUSTAINED DESPITE WITHDRAWAL OF THE CATHETER FROM THE LEFT VENTRICLE INTO THE AORTA. THE PHYSICIAN TREATED THIS WITH A SINGLE EXTERNAL COUNTERSHOCK, RESTORING SINUS RHYTHM. THE REMAINDER OF THE PROCEDURE WAS COMPLETED AND WAS UNEVENTFUL. A FEW HOURS AFTER THE PROCEDURE, THE PATIENT DESCRIBED VAGUE RECALL OF THE CARDIOVERSION EPISODE; HE WAS COMFORTABLE IN HIS HOSPITAL ROOM.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 BIOCARDIA UNIVERSAL DEFLECTABLE GUIDE CATHETER GUIDE CATHETER DQO BIOCARDIA, INC. 00895 00850

Patients

Seq Age Sex Outcome Treatment
1 52 YR Life Threatening| R BIOCARDIA HELICAL INFUSION CATHETER: MODEL 00953| GUIDEWIRE, MAKER AND MODEL UNKNOWN